Categories
- Allergies
- Alternative
- Australian Viagra Pharmacy
- Cancer
- Critical Care
- Depression
- Diseases
- Erectile Dysfunction
- Erectile dysfunction treatmen
- Health Care
- Heart Disease
- Hepatitis
- Illness
- Infections
- Medications
- Mental Health
- News
- Obesity
- Other
- Sexual Disorders
- Sexual Health
- Smoking
- Treatment
- Viagra Australia
Archives
- December 2016
- March 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- April 2014
- May 2013
- March 2013
- December 2012
- November 2012
- October 2012
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
-
Recent Posts
Monthly Archives: December 2012
Survey Instruments
The sleep disorders screening questionnaire used validated, self-report screening tools for OSA (Berlin Questionnaire; sensitivity 0.86, specificity 0.77), moderate to severe insomnia (Athens Insomnia Scale: sensitivity 0.93, specificity 0.85),20 restless legs syndrome (RLS Epidemiology, Symptoms, and Treatment questionnaire: sensitivity 0.82, … Continue reading
Posted in Other
Leave a comment
Study Population and Recruitment
A total of 4957 sworn police officers in North America (United States 97%, Canada 3%) volunteered to participate in either the online or on-site study component. The on-site portion of the study included intense investigations of amunicipal police department serving … Continue reading
Posted in Other
Leave a comment
Sleep Disorders, Health, and Safety in Police Officers
Context Sleep disorders often remain undiagnosed. Untreated sleep disorders among police officers may adversely affect their health and safety and pose a risk to the public. Objective To quantify associations between sleep disorder risk and self-reported health, safety, and performance … Continue reading
Posted in Other
Leave a comment
Retransplantation for recurrent HCV cirrhosis
Retransplantation is the only therapeutic option to achieve long-term survival in patients with decompensated HCV cirrhosis after LT. Retransplantation for this indication ranges from 3.6% to 44%. Patient and graft survival rates after retransplantation are inferior to those after primary … Continue reading
Posted in Hepatitis
Leave a comment
Side effects and safety of PegIFN/RBV therapy
The clinical spectrum of AEs is similar to the non-transplant setting. Dose reductions are frequent and drug discontinuation rates are higher than in nontransplant patients. A major limitation of antiviral therapy is tolerability,particularly with respect to the hematologic AEs of … Continue reading
Posted in Hepatitis
Leave a comment
Pre-emptive antiviral therapy after LT
Preemptive antiviral therapy started within 2-6 weeks after transplantation has the advantage of a relatively low VL and the absence or minimal evidence of histologic recurrence, but is limited by tolerability, particularly in patients with high MELD scores pre-transplantation. Rates … Continue reading
Posted in Infections
Leave a comment
Prophylactic antiviral therapy in cirrhosis
The main goals of treating cirrhotic patients with antiviral therapy are to prevent the complications of the disease, to halt disease progression or allow for the regression of cirrhosis, and to attain sustained viral clearance in order to prevent reinfection … Continue reading
Posted in Diseases
Leave a comment
Management of recurrent HCV infection following liver transplantation. Part 3
Regarding the calcineurin inhibitors (CNI), most of the studies suggest that there is no significant difference between tacrolimus and cyclosporine with respect to their impact on histologically diagnosed HCV recurrence and graft or patient survival (Iacob 2007, Berenguer 2007). Cyclosporine … Continue reading
Posted in Infections
Leave a comment